Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer

October 3rd, 2008 by admin

IntroductionThe increment circumstance occurring at chromosome locus 11q13, reportable in individual assorted cancers, includes a sort of possibleness oncogenes. We hit previously reportable increment of digit much oncogene, CCND1, to be correlated with an inauspicious gist of antagonist in premenopausal boob cancer patients. Overexpression of cyclin D1 accelerator however, confers antagonist status but not a antagonist evoked inauspicious effect. Potentially, co-amplification of an added 11q13 gene, with a resulting accelerator overexpression, is required to drive an unnatural effect. Moreover, during 11q13 increment a redaction of the lateral 11q location has been described. In visit to set the possibleness gist of the redaction we hit examined a designated symbol for this event.MethodArray comparative genomic crossbreeding psychotherapy was engaged to refer and support changes in the factor countenance of a sort of assorted genes function to the 11q chromosomal region, related with CCND1 amplification. The ensuant accelerator countenance of these politician genes was then examined in a clinical touchable of 500 direct boob cancers from premenopausal patients irregular to either antagonist or no adjuvant treatment. The accelerator countenance was also compared to the factor countenance accumulation in a subset of 56 boob cancer samples.
Results:
Cortactin and FADD overexpression was linked to CCND1 amplification, observed by fluorescent in situ hybridization, but was not related with a broken gist of tamoxifen. However, redaction of lateral chromosome 11q, circumscribed as downregulation of the symbol Chk1, was related with an broken antagonist response, and interestingly, also with baritone proliferative boob cancer of baritone grade. For Pak1 and cyclin D1 the accelerator countenance corresponded to the factor countenance data.
Conclusion:
The results inform that some 11q13 related factor products are overexpressed in union with cyclin D1 but not linked to an unnatural gist of tamoxifen. Finally, the redaction of lateral 11q, linked to 11q13 amplification, strength be an essential circumstance moving boob cancer outcome and antagonist response.

Tags: , , , , , ,

Posted in Cancer |

Related posts

Comments are closed.

Recent Posts

Categories

Archives:

Search: